Approval · Notice of Compliance 36298 · 2025
AA-VERAP: Notice of Compliance 36298
Issued October 14, 2025
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 36298
- Date
- October 14, 2025
- Company
- AA Pharma Inc.Toronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Labelling Only
- Reason
- Administrative: Change in manufacturer and product name
Products in this notice
Medicinal ingredients
- VERAPAMIL HCL 80 MG per TAB
- VERAPAMIL HCL 120 MG per TAB